SG
VRTX icon

StoneX Group’s Vertex Pharmaceuticals VRTX Stock Holding History

StoneX Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$995K Buy
2,066
+584
+39% +$259K 0.04% 357
2026
Q1 		$662K Sell
1,482
-715
-33% -$333K 0.04% 350
2025
Q4 		$996K Buy
2,197
+1,642
+296% +$708K 0.04% 352
2025
Q3 		$217K Buy
+555
New +$232K 0.01% 799
2025
Q2 		– Sell
-682
Closed -$331K – 1018
2025
Q1 		$331K Buy
682
+12
+2% +$5.59K 0.02% 595
2024
Q4 		$270K Buy
670
+14
+2% +$6.49K 0.01% 641
2024
Q3 		$305K Sell
656
-192
-23% -$92.2K 0.02% 471
2024
Q2 		$397K Sell
848
-30
-3% -$13K 0.03% 391
2024
Q1 		$367K Buy
878
+113
+15% +$47.8K 0.03% 381
2023
Q4 		$311K Buy
+765
New +$283K 0.03% 402
2023
Q3 		– Sell
-682
Closed -$240K – 738
2023
Q2 		$240K Sell
682
-282
-29% -$95K 0.02% 481
2023
Q1 		$304K Buy
964
+59
+7% +$17.7K 0.03% 403
2022
Q4 		$261K Buy
905
+62
+7% +$18.9K 0.03% 423
2022
Q3 		$244K Buy
843
+32
+4% +$9.21K 0.03% 405
2022
Q2 		$229K Buy
+811
New +$217K 0.03% 500
2017
Q3 		– Sell
-5,839
Closed -$752K – 354
2017
Q2 		$752K Buy
+5,839
New +$703K 0.23% 152

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

StoneX Group's VRTX Position: Q2 2026 in Review

StoneX Group increased its Vertex Pharmaceuticals (VRTX) stake by 39% in Q2 2026, buying an estimated $259K and bringing the position to 2,066 shares worth $995K. The position accounts for 0.04% of the portfolio, ranked #357.

StoneX Group first reported a position in VRTX in Q2 2017 and has held it in 16 quarters since. The position peaked at $996K in Q4 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • StoneX Group held 2,066 shares of Vertex Pharmaceuticals worth $995K as of Q2 2026.
  • StoneX Group bought 584 Vertex Pharmaceuticals shares in Q2 2026, an estimated $259K.
  • Vertex Pharmaceuticals made up 0.04% of StoneX Group's portfolio in Q2 2026, its #357 holding.
  • StoneX Group first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 16 quarters since.
  • StoneX Group's Vertex Pharmaceuticals position peaked at $996K in Q4 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.